About Cinference

Cinference uses deep learning to design de novo protein therapies instead of discovering them in a costly and lengthy experimental process. We combine structure-based protein design with sequence optimization algorithms to explore the uncharted territory of the protein sequence space, enabling us to design proteins with superior therapeutic effects.

Company Highlights
Year Founded

2021

icon-altEmployees

12

Location (HQ)

DEU

Since Last Funding

2 years 3 months

Monthly Website Visitors

3.5M

Last Funding Round

Seed

icon-altYoY Headcount Growth

19.8%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Life Science